Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis

[1]  I. Forgacs,et al.  Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. , 1990, Gut.

[2]  K. Bardhan,et al.  Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine. , 1990, Gut.

[3]  D. Colin-Jones,et al.  Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. , 1990, Gut.

[4]  W. P. Munsell,et al.  Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing. , 1989, Gastroenterology.

[5]  A. Morelli,et al.  Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis. , 1989, Scandinavian Journal of Gastroenterology.

[6]  U. Klotz,et al.  Newer H2-Receptor Antagonists , 1988, Clinical pharmacokinetics.

[7]  J. Richter,et al.  Ambulatory 24-hour esophageal pH monitoring , 1988, Digestive Diseases and Sciences.

[8]  T. Humphries,et al.  Dose—response effect of famotidine on patterns of gastro‐oesophageal reflux , 1988, Alimentary pharmacology & therapeutics.

[9]  F. Baldi,et al.  Oesophageal function before, during, and after healing of erosive oesophagitis. , 1988, Gut.

[10]  P. Zeitoun,et al.  OMEPRAZOLE VERSUS RANITIDINE IN EROSIVE OESOPHAGITIS , 1987, The Lancet.

[11]  U. Klotz,et al.  Pharmacokinetics of famotidine in man. , 1987, International journal of clinical pharmacology, therapy, and toxicology.

[12]  J. Jansen,et al.  DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITIS , 1987, The Lancet.

[13]  A. Blum,et al.  Healing and relapse of reflux esophagitis during treatment with ranitidine. , 1986, Gastroenterology.

[14]  T R DeMeester,et al.  Technique, indications, and clinical use of 24 hour esophageal pH monitoring. , 1980, The Journal of thoracic and cardiovascular surgery.

[15]  P. Zeitoun.  Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis. , 1989, Scandinavian journal of gastroenterology. Supplement.

[16]  V. Corleto,et al.  Loss of Efficacy of Famotidine in the Control of Gastric Acid Secretion in Patients with Zollinger-Ellison Syndrome Reversed by Omeprazole , 1989 .

[17]  S. Matsuno,et al.  Taurocholate-induced gastric damage in rats with obstructive jaundice. , 1989, Scandinavian Journal of Gastroenterology, Supplement.

[18]  M. Kusano,et al.  Once-daily administration of famotidine for reflux esophagitis. , 1987, Scandinavian journal of gastroenterology. Supplement.

[19]  A. McCullough,et al.  A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. , 1987, Gastroenterology.

[20]  S. Yamashita,et al.  Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children. , 1987, Clinical Therapeutics.

[21]  M. Savary,et al.  The esophagus : handbook and atlas of endoscopy , 1978 .